The clinical drug candidate anle138b binds predominantly to a central cavity in lipidic Ab40 fibrils and modulates fibril formation. - Han, Mookyoung; Frieg, Benedikt; Matthes, Dirk; Leonov, Andrei; Ryazanov, Sergey; Giller, Karin; Nimerovsky, Evgeny; Stampolaki, Marianna; Xue, Kai; Overkamp, Kerstin; Dienemann, Christian; Riedel, Dietmar; et al. (Biological Magnetic Resonance Bank, 2025)

phosphorylated Heterochromatin protein 1 alpha solution-state NMR assignment - Zhai, Ziwei; Soman, Aghil; Kuang, Jinglei; Guo, Jiayi; Chen, Yinglu; Zhao, Lei; Prasanna, Chinmayi; Putri, Dhira Anindya A.; Glukhov, Grigory S.; Chng, Choon-Peng P.; Huang, Changjin; Nordenskiold, Lars; et al. (Biological Magnetic Resonance Bank, 2025)

13C, 15N chemical shift assignments of MAK33 VL S20N amyloid fibrils - Hora, Manuel; Sarkar, Riddhiman; Morris, Vanessa; Xue, Kai; Prade, Elke; Harding, Emma; Buchner, Johannes; Reif, Bernd (Biological Magnetic Resonance Bank, 2017)

Ensemble structure the closed state of Lys63-linked diubiquitin in the absence of a ligand - Liu, Zhu; Gong, Zhou; Yang, Ju; Jiang, Wen-Xue; Zhu, Wen-Kai; Guo, Da-Chuan; Zhang, Wei-Ping; Liu, Mai-Li; Tang, Chun (Biological Magnetic Resonance Bank, 2015)

Backbone chemical shift assignment of a glutamate receptor ligand binding domain in complexes with five partial agonists - Fenwick, Michael K.; Oswald, Robert E. (Biological Magnetic Resonance Bank, 2008)